IBA Menown



Coronary heart disease remains the leading cause of mortality in the UK. This review focuses on the contemporary management of patients with acute coronary syndromes and those with stable angina, including the role of primary percutaneous coronary intervention versus fibrinolytic therapy in a UK setting, current and emerging antiplatelet and anticoagulant therapies and the latest guidance on secondary prevention/lifestyle modification.

Keywords Angina, anti-thrombotic therapy, coronary heart disease, myocardial infarction, percutaneous coronary intervention, secondary prevention

Declaration of Interests No conflict of interests declared.